ScholarIQanswers from OpenAlex

Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches

PaperCitations, authors & open-access status

Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches have?

ScholarIQcitation count

Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches has 11 citations in the OpenAlex counts ScholarIQ stores.

When was Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches published?

ScholarIQyear

Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches has 2024 year in the ScholarIQ index.

What is the open-access status of Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches?

ScholarIQoa status

Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches has gold oa status in the ScholarIQ index.

What is the DOI of Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches?

ScholarIQdoi

The DOI for Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches is on the source record.

What is the PMID of Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches?

ScholarIQpmid

The PMID for Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches is on the source record.

What is the OpenAlex record for Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches?

ScholarIQopenalex

The OpenAlex for Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial